Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
Efesovir (2 trials)
Tuberculosis (Phase 3)
Tuberculosis, Multidrug-Resistant (Phase 3)
Trials (2 total)
Trial APIs (1 total)